메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

WALOVI International Cans Make Malaysian Debut, Shining at…

GUANGZHOU, China, Nov. 17, 2025 -- On November 17, 2025, at the Fortune Innovation Forum held in Kuala Lumpur, Guangzhou Wang Lao Ji Great Health Industry Co., Ltd., under Guangzhou Pharmaceutical Holdings Limited, grandly launched its WALOVI international cans in the Malaysian market. Following its successful launch in Singapore on November 7, this move represents another crucial strategic deployment for Wanglaoji within the ASEAN market, marking a new phase of deepened global expansion. At the launch ceremony, Tang Heping, Chief Accountant of Guangzhou Pharmaceutical Holdings
- 김갑성 기자
- 2025-11-17 19:40
Krinwave Expands Boundaries of Medical Imaging Using NV…

SHENZHEN, China, Nov. 17, 2025 -- Krinwave Technology, an innovator in medical imaging, announced plans to release one of the first ultrasound device powered by NVIDIA Jetson Thor. The device fully leverages Jetson Thor's powerful computing performance to support the high-performance requirements of Krinwave's proprietary kOS ultrasound system. This demonstrates an early application of Jetson Thor in ultrasound imaging, further extending its presence in medical imaging and unlocking the potential of advanced computing in diagnostic innovation. Krinwave's proprietary kOS system,
- 김갑성 기자
- 2025-11-17 18:11
AI and Multi-omics are Transforming Cancer Care: APAC Prec…

HONG KONG, Nov. 17, 2025 -- The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a clear message: AI and multi-omics are no longer theoretical - they are driving real-world advancements in cancer care across the Asia-Pacific (APAC) region. Co-organized by the Hong Kong Precision Oncology Society, The Hong Kong Polytechnic University, the Hong Kong Integrated Oncology Centre, the Artificial Intelligence Association of Hong Kong, and supported
- 김갑성 기자
- 2025-11-17 13:45
Akeso's Bispecific Antibody Targeting Aβ and BBB-Expresse…

HONG KONG, Nov. 17, 2025 -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by the National Medical Products Administration (NMPA) to initiate clinical trials for Alzheimer's Disease. AK152 is the first bispecific antibody developed in China for disease-modifying therapy in Alzheimer's Disease, marking a significant breakthrough in the field. Furthermore, it is Akeso's first innovative therapeutic candidate designed to target the central nervous
- 김갑성 기자
- 2025-11-17 10:29
WellsCare Partners with SolnanoMed to Launch IASO and IASO…

[ 메디채널 김갑성 기자 ] Partnership to Bring Innovative Wearable Cold-Laser Therapy to One of Southeast Asia's Fastest-Growing Healthcare Markets SEOUL, South Korea, Nov. 17, 2025 -- WellsCare Inc., a leading South Korean med-tech innovator in wearable cold-laser therapy, today announced that it has signed a supply agreement with SolnanoMed Co., Ltd., one of Thailand's most respected medical device distributors. The agreement follows WellsCare's recent FDA Thai approval for its flagship product, IASO Coldlaser — advanced photobiomodulation (PBM) therapy device designed for effective, drug-fr
- 김갑성 기자
- 2025-11-17 10:00
Fotona Appoints Aimee Desrosiers as Global Chief Marketing…

DALLAS, Nov. 16, 2025 -- Fotona, a global leader in high-performing laser systems and energy-based devices for aesthetic, dental and gynecological applications, today announces the appointment of Aimee Desrosiers as Global Chief Marketing Officer. In this role, Desrosiers will lead Fotona's global marketing organization, guiding brand strategy, digital transformation, and market expansion efforts across more than 70 countries worldwide. Desrosiers is a seasoned leader and marketer with experience partnering with high-growth organizations to accelerate brand and commerci
- 김갑성 기자
- 2025-11-16 18:12
테스칸, 펨토치즐 레이저 기술로 반도체 워크플로 확장

[ 메디채널 김갑성 기자 ] 브르노, 체코 2025년 11월 15일 -- 세계적인 전자현미경 제조기업 테스칸(Tescan)이 차세대 펨토초 레이저(femtosecond laser) 플랫폼 '펨토치즐(FemtoChisel)'을 통해 반도체 포트폴리오를 확장한다. 펨토치즐은 탁월한 속도, 정밀도, 재현성 및 품질로 반도체 샘플 준비 워크플로 향상에 기여할 수 있도록 설계됐다. 펨토치즐은 처리량과 적응성이 모두 중요한 반도체 연구•불량 분석 환경에 적합하도록 특별히 개발됐다. 나노미터 수준의 정밀도와 고처리량 지능형 레이저 가공 기술을 결합해 후속 FIB 연마 공정의 필요성을 획기적으로 줄이면서, 깨끗하고 손상 없는 표면을 제공한다. 이를 통해 현재와 미래 반도체 소재에 대한 연구와 불량 분석 속도를 크게 개선하는 효과를 낸다. 시린 아사프(Sirine Assaf) 테스칸 최고수익책임자(CRO)는 "반도체 연구•불량 분석 팀은 반도체 적층 구조 내 모든 소재 층에서 더 빠르고 신뢰할 수 있는 결과를 내달라는 압박을 지속적으로 받고 있다"면서 "우리는 펨토치즐을 통해 '반도체용 대규모 워크플로(
- 김갑성 기자
- 2025-11-15 23:44
MATELASER Launches W1 REGEN Series -- The World's Lightes…

MIAMI, Fla., Nov. 15, 2025 -- MATELASER, INC., an FDA-certified U.S. manufacturer of therapeutic laser systems, today announced the crowdfunding debut of its W1 REGEN Series, including W1 REGEN and W1 REGEN ULTRA. Weighing only 24 grams per module, the W1 REGEN is the world's lightest wearable medical-grade cold laser — empowering anyone to experience deep-tissue recovery, pain relief, and enhanced circulation anytime, anywhere. Powered by patented VCSEL laser technology and dual wavelengths (660nm red + 810nm near-infrared), the W1 REGEN delivers up to 70mW laser output per mo
- 김갑성 기자
- 2025-11-15 00:00
Overlooking mountains and rivers from high above: Dream-c…

BEIJING , Nov. 14, 2025 -- A news report from China.org.cn on the Shenzhou-21 Crew: Sizzling barbecued chicken wings and mouth-watering steaks, one bite and rich juices burst in your mouth… Too ordinary, you say? But what if this is happening 400km above Earth, at China's space station? On November 1, the six astronauts from China's Shenzhou-20 and Shenzhou-21 crews made a successful rendezvous in orbit. With their new equipment — a hot air oven, they had a BBQ feast in space. The crew for Shenzhou-21 features an astronaut trio born in the 1970s,
- 김갑성 기자
- 2025-11-14 22:00
LODD、アブダビで設計・製造・試験を実施したUAE初のハイブリッド大型貨物無人航空…

アブダビ（UAE）, 2025年11月14日 -- LODD Autonomousは、世界市場に向けてアブダビで設計、製造、試験されたUAE初のハイブリッド垂直離着陸（VTOL）大型貨物機「Hili」の初飛行を成功裏に終えました。アブダビ・オートノマス・ウィーク（Abu Dhabi Autonomous Week）の一環として、Al AinのEmirates Falcon Aviation内にあるLODDの飛行試験施設で行われたこの歴史的イベントは、UAEにとって、自律型航空技術と次世代貨物物流の進歩における大きな到達点となりました。 Hiliの初飛行成功は、LODD Autonomousにとって主要な技術的・運用上の成果であり、先進的な航空宇宙システムの設計・製造する能力をUAEが明確に高めていることを示しています。安全を最優先とする集中的なプログラムを経て誕生したHiliは、迅速かつ精密に、そして妥協のない安全性を保ちながらビジョンを現実にものにしていくUAEの能力を示しています。同機は、厳しい性能と品質基準を満たしながら、記録的なペースで飛行準備を整えました。 250キログラムの積載能力と最大700キロメートルの航続距離を備えたHiliは、ハイブリッド電気推進システムとモジュール式設計を組み合わせ、
- 김갑성 기자
- 2025-11-14 20:54

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 20시 40분